Results 31 to 40 of about 1,030,578 (351)

Assessment of intellectual property management and technology commercialization in animal science research

Indian Journal of Animal Sciences
To understand the innovation-based initiatives in the animal science sector, IP&TM Unit of ICAR has analysed IP management, and technology commercialization/licensing activities.
VIKRAM SINGH, SHIV DATT, NEERU BHOOSHAN   +2 more
doaj   +1 more source

Simulation of Intellectual Property Management on Evolution Driving of Regional Economic Growth

Applied Sciences, 2022
The input, application, and transformation of intellectual property can significantly promote the economic development of a region, but the path and operation mechanism of intellectual property management on regional economic growth are not very clear ...
Xiran Yang, Yong Qi
doaj   +1 more source

Function‐driven design of a surrogate interleukin‐2 receptor ligand

FEBS Letters, EarlyView.
Interleukin (IL)‐2 signaling can be achieved and precisely fine‐tuned through the affinity, distance, and orientation of the heterodimeric receptors with their ligands. We designed a biased IL‐2 surrogate ligand that selectively promotes effector T and natural killer cell activation and differentiation. Interleukin (IL) receptors play a pivotal role in
Ziwei Tang, Zelin Cheng, Teng Li, Fulian Wang, Liangminghui Zhang, Xiuxiu He, Lili Liu, Wei Wang, Aibin Liang, Guang Yang   +9 more
wiley   +1 more source

Commercial Human Spaceflights: Legal Challenges for International Regulation

BRICS Law Journal, 2021
Commercial Human Spaceflight – a new addition to the commercial activities in outer space – is attracting the ultra-rich section of the society.
V. Kumar, K. D. Raju, S. R. Subramanian
doaj   +1 more source

Intellectual property and control

Academic Medicine, 1993
The issue of intellectual property is viewed differently by different groups involved in biomedical research: researchers; academic institutions; corporate, government, and philanthropic sponsors; and society. The members of these groups do not always agree even among themselves; within government and academe, for instance, there are different and ...
openaire   +4 more sources

Report of the Intellectual Property Rights Panel [PDF]

, 1994
Report of the meeting of the Intellectual Property Rights Panel held in September 1994, chaired by M.S. Swaminathan.. The report discusses the history of CGIAR engagement with IPR issues.
CGIAR Intellectual Property Rights Panel, Swaminathan, M.S.   +1 more
core  

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

A Review of Intellectual Property Protection within the CGIAR [PDF]

, 1993
Report of the Center Directors' Committee on Intellectual Property Rights transmitted to those attending ICW93 as background for a panel discussion on IPR and implications for IARCs. The report reviews the various steps taken by the centers and the CGIAR
CGIAR Center Directors Committee on Intellectual Property Rights
core  

Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells

Molecular Oncology, EarlyView.
Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son, Lily L. Remsing Rix, Bin Fang, Eric A. Welsh, Nicole V. Bremer, Valentina Foglizzo, Paola Roa, Nickole Sigcha‐Coello, Yi Liao, Eric B. Haura, Alexander Drilon, John M. Koomen, Emiliano Cocco, Uwe Rix   +13 more
wiley   +1 more source

European Code Against Cancer, 5th edition – hormone replacement therapy, other common medical therapies and cancer

Molecular Oncology, EarlyView.
The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations regarding the use of hormone replacement therapy (HRT), which is positioned as recommendation number 13 of the ECAC5.
Mangesh A. Thorat, Marc Arbyn, David Baldwin, Xavier Castells, Solveig Hofvind, Urska Ivanus, Carlo Senore, Esther Toes‐Zoutendijk, Carlijn van der Aalst, Carlos Canelo‐Aybar, Fiorella Karina Fernández‐Sáenz, Ariadna Feliu, Hajo Zeeb, Andre L. Carvalho, Erica D'Souza, David Ritchie, Carolina Espina, Iris Lansdorp‐Vogelaar, Andrea DeCensi   +18 more
wiley   +1 more source